1. Home
  2. XYL vs DXCM Comparison

XYL vs DXCM Comparison

Compare XYL & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XYL
  • DXCM
  • Stock Information
  • Founded
  • XYL 2011
  • DXCM 1999
  • Country
  • XYL United States
  • DXCM United States
  • Employees
  • XYL N/A
  • DXCM N/A
  • Industry
  • XYL Fluid Controls
  • DXCM Medical/Dental Instruments
  • Sector
  • XYL Industrials
  • DXCM Health Care
  • Exchange
  • XYL Nasdaq
  • DXCM Nasdaq
  • Market Cap
  • XYL 29.3B
  • DXCM 28.0B
  • IPO Year
  • XYL N/A
  • DXCM 2005
  • Fundamental
  • Price
  • XYL $121.90
  • DXCM $86.32
  • Analyst Decision
  • XYL Buy
  • DXCM Buy
  • Analyst Count
  • XYL 11
  • DXCM 17
  • Target Price
  • XYL $152.10
  • DXCM $99.29
  • AVG Volume (30 Days)
  • XYL 1.1M
  • DXCM 3.7M
  • Earning Date
  • XYL 02-04-2025
  • DXCM 02-13-2025
  • Dividend Yield
  • XYL 1.19%
  • DXCM N/A
  • EPS Growth
  • XYL 41.22
  • DXCM 83.21
  • EPS
  • XYL 3.42
  • DXCM 1.67
  • Revenue
  • XYL $8,424,000,000.00
  • DXCM $3,954,000,000.00
  • Revenue This Year
  • XYL $16.51
  • DXCM $13.10
  • Revenue Next Year
  • XYL $4.94
  • DXCM $14.72
  • P/E Ratio
  • XYL $35.68
  • DXCM $51.77
  • Revenue Growth
  • XYL 24.76
  • DXCM 16.19
  • 52 Week Low
  • XYL $111.66
  • DXCM $62.34
  • 52 Week High
  • XYL $146.08
  • DXCM $142.00
  • Technical
  • Relative Strength Index (RSI)
  • XYL 59.95
  • DXCM 66.92
  • Support Level
  • XYL $113.26
  • DXCM $73.62
  • Resistance Level
  • XYL $117.88
  • DXCM $82.24
  • Average True Range (ATR)
  • XYL 2.00
  • DXCM 2.84
  • MACD
  • XYL 0.88
  • DXCM 0.58
  • Stochastic Oscillator
  • XYL 94.74
  • DXCM 94.56

About XYL Xylem Inc. New

Xylem is a global leader in water technology and offers a wide range of solutions, including the transport, treatment, testing, and efficient use of water for customers in the utility, industrial, commercial, and residential sectors. Xylem was spun off from ITT in 2011. Based in Rye Brook, New York, Xylem has a presence in over 150 countries and employs 16,200. The company generated $7.4 billion in revenue in 2023.

About DXCM DexCom Inc.

Dexcom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.

Share on Social Networks: